Advertisement

Topics

bluebird bio to Present at Alliance for Regenerative Medicine’s 6th Annual Cell & Gene Therapy Investor Day

08:00 EDT 16 Apr 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
bluebird bio, Inc. (Nasdaq:BLUE) today announced that members of the management team will present at Alliance for Regenerative Medicine’s 6th Annual Cell & Gene Therapy Investor Day on Tuesday, April 17, at 11:25 a.m. ET...

Other Sources for this Article

Media
Stephanie Fagan, 201-572-9581
sfagan@bluebirdbio.com
or
Investors
Elizabeth Pingpank, 617-914-8736
epingpank@bluebirdbio.com

NEXT ARTICLE

More From BioPortfolio on "bluebird bio to Present at Alliance for Regenerative Medicine’s 6th Annual Cell & Gene Therapy Investor Day"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...